We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Can’t Shake Suit Over Deceptive Robitussin Labels

Law360 (April 13, 2018, 7:39 PM EDT) -- An Illinois federal judge Friday refused to toss nationwide class claims from a suit alleging Pfizer Inc. overcharged consumers for its “Maximum Strength” Robitussin compared to its regular version, finding that the label could be plausibly considered deceptive based on the drugs’ relative ingredient mixes.

U.S. District Judge Gary Feinerman refused to toss consumer Karmel Al Haj’s proposed class action claiming Pfizer violated every state’s consumer protection and unjust enrichment laws by charging more for its “Maximum Strength” Robitussin compared to its “Regular Strength” version, even...
To view the full article, register now.




Case Information

Case Title

Al Haj et al v. Pfizer Inc

Case Number



Illinois Northern

Nature of Suit

110(Contract: Insurance)


Honorable Gary Feinerman

Date Filed

September 18, 2017

Law Firms


Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.